While there is no shortage of AI models out there, I primarily turn to Grok when my research hits a wall, or when I need ...

A n open-source tool that perfectly blends the freedom of handwriting with the power of digital organization is a rare find, ...

A year ago, Astellas was celebrating the first-in-class approval of its claudin 18.2-targeting cancer drug Vyloy for gastric cancers. Now, a bid to expand its label into pancreatic cancer has hit the ...